Dr Emma Hodcroft on Twitter: "We now have B.1.1.529 sequences (designed at @nextstrain clade 21K) up in our Africa build. You can check them out below. These are from South Africa &
Omicron (B.1.1529) variant | Expression vectors | InvivoGen
Emerging evidence on Omicron (B.1.1.529) SARS‐CoV‐2 variant - Sharma - 2022 - Journal of Medical Virology - Wiley Online Library
Addgene: pVRC8400-SARS-CoV-2-S2P-B.1.1.529-AVI
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 | MMWR
Addgene: pTwist-SARS-CoV-2 Δ18 B.1.1.529
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study - The Lancet Infectious Diseases
![Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR](https://pbs.twimg.com/media/FFCWwQDXEAErpCL.jpg "Mia Malan on Twitter: \"[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR")
Mia Malan on Twitter: "[Thread] What is the potential impact of the new B. 1.1.529 #COVID19 variant? @rjlessells: 1. It's relatively simple to detect some B.1.1.529 cases, as it's possible to use PCR
Viruses | Free Full-Text | A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
Vinod Scaria on Twitter: "What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations An updated thread on emerging evidence. https://t.co/D8nzB6ssgg" / Twitter
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
What is a variant? An expert explains | News | Wellcome
Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
View of SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S | Acta Biochimica Polonica
SARS-CoV-2 Mutations Research Tools Tracker | www.antibodies-online.com
Frontiers | SARS-CoV-2's Variants of Concern: A Brief Characterization
Addgene: pVRC8400-SARS-CoV-2-NTD-B.1.1.529-AVI
Antibody evasion properties of SARS-CoV-2 Omicron sublineages | Nature
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron | Nature
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure | Science
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022 | MMWR
